Biomerica (BMRA) Other Accumulated Expenses (2020)

Biomerica (BMRA) reported Other Accumulated Expenses of $6670.0 for Q2 2020.

Biomerica (BMRA) Other Accumulated Expenses (2020) Analysis & Trends

Biomerica (BMRA) has 1 years of Other Accumulated Expenses data on file, last reported at $6670.0 in Q2 2020.

For the quarter ending Q2 2020, Other Accumulated Expenses changed N/A year-over-year to $6670.0; the trailing twelve-month figure through May 2020 stood at $6670.0 (changed N/A YoY), and the FY2020 full-year result was $6670.0, changed N/A from the prior year.
Other Accumulated Expenses was little changed at $6670.0 in Q2 2020.
In the past five years, Other Accumulated Expenses ranged from a high of $6670.0 in Q2 2020 to a low of $6670.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Biomerica	4.85 Mn	3.51 Mn	-44,000.00

Download Data

Date	Value
May 31, 2020	6,670.00